Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CUE Cue Biopharma, Inc.

未开盘 05-09 16:00:00 EDT

1.92

+0.01

+0.26%

盘后1.92

+0.000.00%

17:27 EDT

最高1.98	最低1.84	成交量17.13万
今开1.90	昨收1.91	日振幅7.26%
总市值9,315万	流通市值8,690万	总股本4,864万
成交额32.61万	换手率0.38%	流通股本4,538万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CUE","market":"US","secType":"STK","nameCN":"Cue Biopharma, Inc.","latestPrice":1.915,"timestamp":1715284800000,"preClose":1.91,"halted":0,"volume":171338,"hourTrading":{"tag":"盘后","latestPrice":1.915,"preClose":1.915,"latestTime":"17:27 EDT","volume":5,"amount":9.67,"timestamp":1715290056679},"delay":0,"floatShares":45379232,"shares":48643316,"eps":-1.108801,"marketStatus":"未开盘","marketStatusCode":0,"change":0.005,"latestTime":"05-09 16:00:00 EDT","open":1.9,"high":1.9787,"low":1.84,"amount":326108.454956,"amplitude":0.072618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.108801,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"listingDate":1514869200000,"adjPreClose":1.91,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.915,"preClose":1.915,"latestTime":"17:27 EDT","volume":5,"amount":9.67,"timestamp":1715290056679},"volumeRatio":0.501039},"requestUrl":"/m/hq/s/CUE","defaultTab":"news","newsList":[{"id":"2434029663","title":"Cue 生物制药公司公布截至一月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434029663","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434029663?lang=zh_cn&edition=full","pubTime":"2024-05-10 06:05","pubTimestamp":1715292301,"startTime":"0","endTime":"0","summary":"   * Cue Biopharma Inc   报告，截至1月底的季度调整后每股亏损25美分，高于去年同期的每股-29美分。五位分析师对该季度的平均预期是每股亏损 28 美分。华尔街预期为每股-32美分至-24美分。* Cue Biopharma Inc公布的本季度每股收益为亏损25美分。* 该公司当季亏损1235万美元。* Cue Biopharma Inc本季度股价上涨了1.1%，今年迄今为止亏损了27.7%。* 生物技术和医学研究同行的平均一致建议也是 \"强力买入\"。华尔街对 Cue Biopharma Inc 的 12 个月目标价中位数为 8.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433881721","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433881721","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433881721?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:34","pubTimestamp":1715175266,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时34分，Cue Biopharma, Inc.股票出现异动，股价快速跳水5.50%。截至发稿，该股报2.06美元/股，成交量1.4511万股，换手率0.03%，振幅2.98%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Adaptive Biotechnologies Corporation、Repare Therapeutics Inc.、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为201.13%、28.33%、10.99%，振幅较大的相关个股有Y-Mabs Therapeutics, Inc.、Adaptive Biotechnologies Corporation、Veru Inc.，振幅分别为14.76%、13.50%、9.20%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082134278ae8de6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082134278ae8de6b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433477196","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433477196","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433477196?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:20","pubTimestamp":1715005255,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时20分，Cue Biopharma, Inc.股票出现异动，股价急速拉升5.16%。截至发稿，该股报2.24美元/股，成交量4.8166万股，换手率0.10%，振幅6.57%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Nrx Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为988.43%、674.06%、52.75%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、38.10%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622205687e85d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622205687e85d62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432183437","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.85%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432183437","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432183437?lang=zh_cn&edition=full","pubTime":"2024-05-04 00:18","pubTimestamp":1714753085,"startTime":"0","endTime":"0","summary":"北京时间2024年05月04日00时18分，Cue Biopharma, Inc.股票出现异动，股价急速上涨5.85%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Allarity Therapeutics, Inc.、Jaguar Health, Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为244.62%、41.02%、39.68%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Eliem Therapeutics, Inc，振幅分别为59.38%、48.94%、37.31%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050400180587e85822&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050400180587e85822&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432255975","title":"Cue Biopharma Inc   预计每股亏损 28 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432255975","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432255975?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:57","pubTimestamp":1714737434,"startTime":"0","endTime":"0","summary":"   * Cue Biopharma Inc    将于5月7日公布截至2024年3月31日的财报(估计)，预计该公司的季度收入将出现增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收预计将从一年前的18.7万美元增至121.3万美元，增幅为548.7%。* LSEG 分析师对 Cue Biopharma Inc 的平均预期是每股亏损 28 美分。* 华尔街对 Cue Biopharma Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 1.88 美元。5月3日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432798108","title":"Cue Biopharma, Inc.盘中异动 大幅下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432798108","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432798108?lang=zh_cn&edition=full","pubTime":"2024-05-03 00:06","pubTimestamp":1714665997,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日00时06分，Cue Biopharma, Inc.股票出现波动，股价大幅下挫5.51%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Aptevo Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4000.32%、621.85%、150.17%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Context Therapeutics Inc.，振幅分别为140.88%、77.95%、38.23%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030006387925b3fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030006387925b3fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432577747","title":"Cue Biopharma, Inc.盘中异动 早盘急速下挫5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432577747","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432577747?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:39","pubTimestamp":1714570749,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时39分，Cue Biopharma, Inc.股票出现异动，股价大幅下跌5.61%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tg Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为467.77%、40.06%、16.09%，振幅较大的相关个股有Promis Neurosciences Inc.、Carmell Corporation、Cytomx Therapeutics, Inc.，振幅分别为30.95%、21.50%、20.25%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121390987e852bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121390987e852bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431816926","title":"Cue Biopharma, Inc.盘中异动 大幅拉升5.49%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431816926","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431816926?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:56","pubTimestamp":1714409790,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时56分，Cue Biopharma, Inc.股票出现波动，股价快速拉升5.49%。截至发稿，该股报1.44美元/股，成交量6.6486万股，换手率0.14%，振幅3.66%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Calidi Biotherapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Celularity Inc C/Wts 16/07/2026 涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Annovis Bio, Inc.较为活跃，换手率分别为990.42%、57.36%、56.96%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为98.32%、79.12%、75.06%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000563087e84cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000563087e84cb1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430026205","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.67%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430026205","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430026205?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:28","pubTimestamp":1714141692,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时28分，Cue Biopharma, Inc.股票出现异动，股价急速下跌5.67%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1053.46%、100.21%、34.57%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为73.97%、73.12%、66.85%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622281287e84388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622281287e84388&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281891","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌7.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281891","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430281891?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:55","pubTimestamp":1714053347,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时55分，Cue Biopharma, Inc.股票出现异动，股价大幅下挫7.04%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为1241.29%、200.70%、8.50%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为40.85%、32.10%、19.29%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252155487a55b55b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252155487a55b55b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429144286","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429144286","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429144286?lang=zh_cn&edition=full","pubTime":"2024-04-24 03:49","pubTimestamp":1713901761,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日03时49分，Cue Biopharma, Inc.股票出现异动，股价大幅下跌5.09%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.64%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 、Abvc Biopharma, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2728.59%、182.87%、65.65%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为100.59%、80.08%、66.15%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240349217922b7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240349217922b7e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428096345","title":"Cue Biopharma, Inc.盘中异动 快速上涨5.02%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428096345","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428096345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:37","pubTimestamp":1713361035,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时37分，Cue Biopharma, Inc.股票出现异动，股价快速拉升5.02%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.56%、22.96%、20.79%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Jaguar Health, Inc.、Viracta Therapeutics, Inc.，振幅分别为25.30%、16.55%、15.75%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172137157a537bbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172137157a537bbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427878876","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427878876","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427878876?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:49","pubTimestamp":1713278993,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时49分，Cue Biopharma, Inc.股票出现异动，股价大幅跳水5.33%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Jaguar Health, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为2395.91%、136.55%、130.27%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Palisade Bio, Inc.，振幅分别为101.94%、97.81%、80.27%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622495387e80ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622495387e80ffb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427488002","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427488002","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427488002?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:41","pubTimestamp":1713192105,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时41分，Cue Biopharma, Inc.股票出现异动，股价大幅下挫5.14%。截至发稿，该股报1.66美元/股，成交量2.8575万股，换手率0.06%，振幅5.71%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 、Soligenix, Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1307.59%、1054.05%、746.83%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、90.57%、80.04%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152241457a52dde2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152241457a52dde2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426117266","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.83%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426117266","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426117266?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:33","pubTimestamp":1712846034,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时33分，Cue Biopharma, Inc.股票出现波动，股价急速下挫5.83%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。该信息摘要如下：奥本海默：维持Cue Biopharma评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112233557a522ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112233557a522ede&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426194073","title":"Cue Biopharma, Inc.盘中异动 急速下挫6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426194073","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426194073?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:33","pubTimestamp":1712669582,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时33分，Cue Biopharma, Inc.股票出现波动，股价急速跳水6.86%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。该信息摘要如下：奥本海默：维持Cue Biopharma评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092133028b03a004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092133028b03a004&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426196149","title":"奥本海默：维持Cue Biopharma(CUE.US)评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426196149","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426196149?lang=zh_cn&edition=full","pubTime":"2024-04-09 20:45","pubTimestamp":1712666716,"startTime":"0","endTime":"0","summary":"奥本海默：维持Cue Biopharma(CUE.US)评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092045218b037f00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092045218b037f00&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426378041","title":"美国研究综述-芝加哥商品交易所集团、达尼莫尔科技公司、洲际交易所","url":"https://stock-news.laohu8.com/highlight/detail?id=2426378041","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426378041?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:12","pubTimestamp":1712646726,"startTime":"0","endTime":"0","summary":"    路透社4月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括芝加哥商品交易所集团、丹尼默科技公司和洲际交易所。* 洲际交易所  ：杰富瑞将目标价从144美元上调至159美元             * 纳斯达克公司   ：杰富瑞将目标价从56美元上调至59美元             * Papa John's International Inc   ：Keybanc将目标价从84美元下调至78美元 以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426976424","title":"Cue Biopharma, Inc.2023财年实现净利润-50.73百万美元，同比增加4.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426976424","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426976424?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:04","pubTimestamp":1712617487,"startTime":"0","endTime":"0","summary":"12月31日，Cue Biopharma, Inc.公布财报，公告显示公司2023财年净利润为-50.73百万美元，同比增加4.30%；其中营业收入为5.49百万美元，同比增加339.20%，每股基本收益为-1.11美元。从资产负债表来看，Cue Biopharma, Inc.总负债24.45百万美元，其中短期债务7.33百万美元，资产负债比为2.52，流动比率为3.02。机构评级：截至2023年12月31日，当前有4家机构对Cue Biopharma, Inc.目标价做出预测，其中目标均价为9.75美元，其中最低目标价为6.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409070455875629af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409070455875629af&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cuebiopharma.com","stockEarnings":[{"period":"1week","weight":0.0186},{"period":"1month","weight":0.0079},{"period":"3month","weight":-0.1781},{"period":"6month","weight":-0.171},{"period":"1year","weight":-0.5951},{"period":"ytd","weight":-0.2746}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cue Biopharma, Inc.于2014年12月31日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发一种新型的专有类生物药物，用于选择性调节人体免疫系统，以治疗范围广泛的癌症和自身免疫性疾病。虽然目前处于临床前开发阶段，但他们相信，他们的CUE Biologics平台为当前免疫疗法面临的挑战提供了一个潜在的变革性解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003573},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.028558},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.01855},{"month":4,"riseRate":0.571429,"avgChangeRate":0.101525},{"month":5,"riseRate":0.571429,"avgChangeRate":0.043407},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.121997},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.084473},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.060894},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.099594},{"month":11,"riseRate":0.833333,"avgChangeRate":0.169868},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007258}],"exchange":"NASDAQ","name":"Cue Biopharma, Inc.","nameEN":"Cue Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cue Biopharma, Inc.,CUE,Cue Biopharma, Inc.股票,Cue Biopharma, Inc.股票老虎,Cue Biopharma, Inc.股票老虎国际,Cue Biopharma, Inc.行情,Cue Biopharma, Inc.股票行情,Cue Biopharma, Inc.股价,Cue Biopharma, Inc.股市,Cue Biopharma, Inc.股票价格,Cue Biopharma, Inc.股票交易,Cue Biopharma, Inc.股票购买,Cue Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况